Hang Feng Technology Innovation Co., Ltd. Completes Initial Public Offering
September 16, 2025 - 02:07
Hong Kong, Sept. 15, 2025 — Hang Feng Technology Innovation Co., Ltd., a company specializing in corporate management consulting and asset management services, has successfully closed its initial public offering (IPO). The offering consisted of 1,375,000 ordinary shares, each with a par value of $0.0001, priced at $4.00 per share.
The ordinary shares of Hang Feng began trading on the Nasdaq Capital Market on September 15, marking a significant milestone for the company as it seeks to expand its operations and enhance its market presence. The funds raised through this IPO are expected to be utilized for strategic initiatives, including the development of new services and the enhancement of existing offerings.
This move into the public market reflects Hang Feng's commitment to growth and innovation in the competitive landscape of corporate services. The successful completion of the IPO is a testament to the company’s strong business model and the confidence investors have in its future prospects.
MORE NEWS
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...